TrialBreast cancer research : BCR2025

8MW0511, a novel, long-acting granulocyte-colony stimulating factor fusion protein for the prevention of chemotherapy-induced neutropenia: final results from the phase III clinical trial.

Biyun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.